Search filters

Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 89
  • 14
  • 169
  • 695
  • 449
  • 14
  • 31
  • 1
  • 4
  • 647

Found 697 none trials

A listing of none medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

C
Chace Brokaw Chace Brokaw
99 years or below
Female
Phase 1
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol  PI123
E
EDWARD STADTMAUER
99 years or below
All genders
See protocol section 2 See protocol section 2 See protocol section 2
 Evaluation of Vascular Health Profile in Predicting Venous Thromboembolism
1 years - 99 years
All genders
The main goal of this study is to utilize previously validated cytometric markers of to identify cancer patients at high risk of VTE. The primary outcome will be DVT or pulmonary embolism (PE). Patients with pancreatic and brain cancer will be enrolled as these patients are known to have higher …
 Cerebrovascular reactivity assessed with functional near-infrared spectroscopy as a biomarker of traumatic microvascular injury after traumatic brain injury
99 years or below
All genders
Traumatic cerebrovascular injury (TCVI) is common after traumatic brain injury (TBI) and an attractive target for therapeutic intervention. We will longitudinally measure cerebrovascular reactivity (CVR) by functional near-infrared spectroscopy (fNIRS) in acute (3 days from injury), subacute, and chronic phases after TBI as a biomarker of TCVI as compared to …
 Alzheimers Disease Neuroimaging Initiative 3 (ADNI3)
55 years - 90 years
All genders
Since its launch in 2004, the overarching aim of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI1, ADNI-GO, and ADNI2 studies that have been combined public/private collaborations between academia and industry to determine the …
 A Phase 1b  Multicenter  Open-Label  Safety  Tolerability  and Activity Study of SYNT001 in Subjects with Chronic  Stable Warm Autoimmune Hemolytic Anemia (WAIHA)
99 years or below
All genders
Phase 1
WAIHA is caused by antibodies (proteins) that attach to red blood cells and causes their destruction. This causes anemia, which means the red blood cell count in the body becomes low. This medical research study is being done to find out more information about the investigational drug SYNT001 for the …
321 - 330 of 697